1.Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim Y-H, McAnulty JH, Zheng Z-J et al: Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study. Circulation 2014, 129(8):837–847.
2.Kim MH, Johnston SS, Chu B-C, Dalal MR, Schulman KL: Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States. Circulation-Cardiovascular Quality And Outcomes 2011, 4(3):313–320.
3.Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TSM: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114(2):119–125.
4.Freedman B, Potpara TS, Lip GYH: Stroke prevention in atrial fibrillation. Lancet 2016, 388(10046):806–817.
5.Kotecha D, Piccini JP: Atrial fibrillation in heart failure: what should we do? European Heart Journal 2015, 36(46):3250-U3258.
6.Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H-C, Heidbuchel H, Hendriks J et al: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal 2016, 37(38):2893-+.
7.Quinn JJ, Chang HY: Unique features of long non-coding RNA biogenesis and function. Nature Reviews Genetics 2016, 17(1):47–62.
8.Uchida S, Dimmeler S: Long Noncoding RNAs in Cardiovascular Diseases. Circulation Research 2015, 116(4):737–750.
9.Gurha P: Noncoding RNAs in cardiovascular diseases. Current opinion in cardiology 2019, 34(3):241–245.
10.Viereck J, Thum T: Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury. Circulation Research 2017, 120(2):381–399.
11.Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP: Noncoding RNA Gas5 Is a Growth Arrest- and Starvation-Associated Repressor of the Glucocorticoid Receptor. Science Signaling 2010, 3(107).
12.Wang Y-N-Z, Shan K, Yao M-D, Yao J, Wang J-J, Li X, Liu B, Zhang Y-Y, Ji Y, Jiang Q et al: Long Noncoding RNA-GAS5 A Novel Regulator of Hypertension-Induced Vascular Remodeling. Hypertension 2016, 68(3):736-+.
13.Yin Q, Wu A, Liu M: Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease. Medical Science Monitor 2017, 23:6042–6048.
14.Tao H, Zhang J-G, Qin R-H, Dai C, Shi P, Yang J-J, Deng Z-Y, Shi K-H: LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR–21 via PTEN/MMP–2 signaling pathway. Toxicology 2017, 386:11–18.
15.Allessie M, Ausma J, Schotten U: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research 2002, 54(2):230–246.
16.Adriaens C, Standaert L, Barra J, latil M, Verfaillie A, Kalev P, Boeckx B, Wijnhoven PWG, Radaelli E, Vermi W et al: p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nature Medicine 2016, 22(8):861-+.
17.Liu Z, Wu K, Wu J, Tian D, Chen Y, Yang Z, Wu A: NEAT1 is a potential prognostic biomarker for patients with nasopharyngeal carcinoma. Journal Of Cellular Biochemistry 2019, 120(6):9831–9838.
18.Ahmed ASI, Dong K, Liu J, Wen T, Yu L, Xu F, Kang X, Osman I, Hu G, Bunting KM et al: Long noncoding RNA NEAT1 (nuclear paraspeckle assembly transcript 1) is critical for phenotypic switching of vascular smooth muscle cells. Proceedings Of the National Academy Of Sciences Of the United States Of America 2018, 115(37):E8660-E8667.
19.Gast M, Rauch B, Haghikia A, Nakagawa S, Haas J, Stroux A, Schmidt D, Schumann P, Weiss S, Jensen L et al: Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients. Cardiovascular research 2019.
20.Zhu Y, Feng Z, Jian Z, Xiao Y: Long noncoding RNA TUG1 promotes cardiac fibroblast transformation to myofibroblasts via miR–29c in chronic hypoxia. Molecular Medicine Reports 2018, 18(3):3451–3460.
21.Shi L, Tian C, Sun L, Cao F, Meng Z: The lncRNA TUG1/miR–145–5p/FGF10 regulates proliferation and migration in VSMCs of hypertension. Biochemical And Biophysical Research Communications 2018, 501(3):688–695.
22.Li FP, Lin DQ, Gao LY: LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA–21/PTEN axis. European Review for Medical And Pharmacological Sciences 2018, 22(21):7439–7447.
23.Wang X-S, Zhang Z, Wang H-C, Cai J-L, Xu Q-W, Li M-Q, Chen Y-C, Qian X-P, Lu T-J, Yu L-Z et al: Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clinical Cancer Research 2006, 12(16):4851–4858.
24.Liu Y, Zhou D, Li G, Ming X, Tu YF, Tian J, Lu H, Yu B: Long Non Coding RNA-UCA1 Contributes to Cardiomyocyte Apoptosis by Suppression of p27 Expression. Cellular Physiology And Biochemistry 2015, 35(5):1986–1998.
25.Yan Y, Zhang B, Liu N, Qi C, Xiao Y, Tian X, Li T, Liu B: Circulating Long Noncoding RNA UCA1 as a Novel Biomarker of Acute Myocardial Infarction. Biomed Research International 2016.
26.Xuan L, Sun L, Zhang Y, Huang Y, Hou Y, Li Q, Guo Y, Feng B, Cui L, Wang X et al: Circulating long non-coding RNAs NRON and MHRT as novel predictive biomarkers of heart failure. Journal Of Cellular And Molecular Medicine 2017, 21(9):1803–1814.
27.Tan Q, Zuo J, Qiu S, Yu Y, Zhou H, Li N, Wang H, Liang C, Yu M, Tu J: Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosis. International Journal Of Oncology 2017, 50(5):1729–1738.
28.Li C, Lv Y, Shao C, Chen C, Zhang T, Wei Y, Fan H, Lv T, Liu H, Song Y: Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis. Journal of cellular physiology 2019.
29.Shen J, Hodges TR, Song R, Gong Y, Calin GA, Heimberger AB, Zhao H: Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma. Molecular Carcinogenesis 2018, 57(1):137–141.
30.Han L, Ma P, Liu S-M, Zhou X: Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects. Tumor Biology 2016, 37(5):6847–6854.
31.Liang W, Lv T, Shi X, Liu H, Zhu Q, Zeng J, Yang W, Yin J, Song Y: Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer. Medicine 2016, 95(37).
32.Qian C, Li H, Chang D, Wei B, Wang Y: Identification of functional lncRNAs in atrial fibrillation by integrative analysis of the lncRNA-mRNA network based on competing endogenous RNAs hypothesis. Journal Of Cellular Physiology 2019, 234(7):11620–11630.
33.Healey JS, Connolly SJ: Atrial fibrillation: Hypertension as a causative agent, risk factor for complications, and potential therapeutic target. American Journal Of Cardiology 2003, 91(10):9G–14G.
34.Yin X, Zhao Y, Xi Y, Cheng N, Xia Y, Zhang S, Dong Y, Chang D, Cheng J, Yang Y et al: The Early Stage of the Atrial Electroanatomic Remodeling as Substrates for Atrial Fibrillation in Hypertensive Patients. Journal Of the American Heart Association 2014, 3(5).
35.Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett ELC: ASYMPTOMATIC ARRHYTHMIAS IN PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL-FIBRILLATION AND PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA. Circulation 1994, 89(1):224–227.
36.Hamer ME, Wilkinson WE, Clair WK, Page RL, McCarthy EA, Pritchett ELC: INCIDENCE OF SYMPTOMATIC ATRIAL-FIBRILLATION IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA. Journal Of the American College Of Cardiology 1995, 25(5):984–988.
37.Khachab H, Brembilla-Perrot B: Prevalence of atrial fibrillation in patients with history of paroxysmal supraventricular tachycardia. International Journal Of Cardiology 2013, 166(1):221–224.
38.Padfield GJ, Steinberg C, Swampillai J, Qian H, Connolly SJ, Dorian P, Green MS, Humphries KH, Klein GJ, Sheldon R et al: Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation. Heart Rhythm 2017, 14(6):801–807.
39.Dzeshka MS, Lip GYH, Snezhitskiy V, Shantsila E: Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications. Journal Of the American College Of Cardiology 2015, 66(8):943–959.
40.Liu HL, Chen CH, Sun YJ: Overexpression of lncRNA GAS5 attenuates cardiac fibrosis through regulating PTEN/MMP–2 signal pathway in mice. European Review for Medical And Pharmacological Sciences 2019, 23(10):4414–4418.